| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 83 | 15.152 | 39.535 | 53.779 | 55.454 |
| Total Income - EUR | - | - | - | 0 | 0 | 83 | 15.152 | 39.536 | 53.779 | 55.455 |
| Total Expenses - EUR | - | - | - | 192 | 507 | 1.517 | 7.773 | 10.050 | 14.071 | 17.818 |
| Gross Profit/Loss - EUR | - | - | - | -192 | -507 | -1.434 | 7.379 | 29.486 | 39.708 | 37.637 |
| Net Profit/Loss - EUR | - | - | - | -192 | -507 | -1.434 | 7.379 | 29.139 | 39.197 | 36.057 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Dobrasmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 1 | 0 | 51 | 8.332 | 29.713 | 39.796 | 81.060 |
| Inventories | - | - | - | 0 | 0 | 0 | 108 | 137 | 96 | 17 |
| Receivables | - | - | - | 0 | 0 | 0 | 953 | 22.238 | 24.490 | 29.519 |
| Cash | - | - | - | 1 | 0 | 51 | 7.271 | 7.338 | 15.210 | 51.524 |
| Shareholders Funds | - | - | - | -149 | -653 | -2.038 | 5.386 | 29.231 | 39.290 | 36.148 |
| Social Capital | - | - | - | 43 | 42 | 79 | 77 | 77 | 77 | 76 |
| Debts | - | - | - | 150 | 653 | 2.089 | 2.946 | 482 | 579 | 45.128 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dobrasmed S.r.l.